Pharmacology journal pulls paper because third party “compromised” peer review

BJCP CoverThe British Journal of Clinical Pharmacology (BCP) has retracted a 2015 document about treating heart failure after deciding its look closely review process had been compromised.

This article is one of the many we’ve noticed latterly that have been felled by the actions of a “third part party” — in this case, a written document editing company called EditPub.

The newly retracted journal, “rhBNP therapy can improve clinical outcomes and vanquish in-hospital mortality compared with dobutamine in inclination failure patients: a meta-analysis,” has not still been cited, according to Thomson Reuters Web of Science.

Here’s the abjuration note, which tells us a morsel more:

The above article, published online up~ 28th November 2015 in Wiley Online Library (, and in volume 81, pp. 174–185, has been retracted ~ dint of. agreement between the authors, the newspaper Editor in Chief, Professor A Cohen, and John Wiley & Sons Limited. The revocation has been agreed owing to testimony indicating that the peer review of this paper was compromised. The authors were unconscious of the actions of the third party responsible for compromising the peer review.

Xiao-Feng Long, last composer of the paper from Dalian University in China, told us the third party involved with processing the writing is a company called “EditPub.” Long added the authors were “shocked” ~ dint of. what happened:

We are very close and regret that our own scholastic achievements have lost the opportunity to make public in British Journal of Clinical Pharmacology.

Long uttered the team was still confident in the paper:

Of course, we firmly believe…the genuineness of our academic results, the understanding for our loss of the publishing chance; fit might be closely correlated with the address of our lacking of adequate of the college study ability, rather than the likewise-called academic fraud. We therefore shape up our mind not to bestow up our research and try our most wise to improve our academic research power .

Adam Cohen, editor-in-chief of BCP and essential executive officer of the Centre with respect to Human Drugs Research at Leiden in the Netherlands, told us he plans to promulgate an editorial titled, “Organised gross offence against peer review,” which elect give “the full picture” and impart “all names” of parties involved with the case. Cohen, however, declined to remark on the specifics until the editorial is published.

In complete, that’s more than 300 papers that be in possession of so far been retracted for fake or rigged fellow review. Here’s our 2014 Nature point about the issue if you require a bit more background on the head.

We’ve contacted EditPub for a make notes, and will update the post suppose that we hear back.

Like Retraction Watch? Consider fabrication a tax-deductible contribution to bed our growth. You can also come us on Twitter, like us forward Facebook, add us to your RSS reader, sign up in successi~ our homepage for an email every time there’s a new stigmatize , or subscribe to our new quotidian digest. Click here to review our Comments Policy. For a steal peek at what we’re laboring on, click here.


Wellbutrin-next release type, but not sustained form form-and Anafranil, which often be in possession of a better associated risk, along through Desyrel together with Serzone, which unfortunately don’t rise seizure probability in a single one respect).

Recent Comments